Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Pelizaeus-Merzbacher disease (PMD) is a severe X-linked leukodystrophy linked to PLP1 mutations.
• Existing research implicates unfolded protein response and ER stress, but genotype-phenotype correlations are incomplete.

Purpose of the Study:

• To investigate novel pathogenetic mechanisms in PMD beyond ER stress.
• To evaluate iron chelation as a therapeutic strategy for PMD.

Main Methods:

• Utilized patient-derived induced pluripotent stem cells (iPSCs) to generate oligodendrocytes.
• Analyzed oligodendrocyte cell death pathways, focusing on ferroptosis hallmarks.
• Tested iron chelation therapy in vitro and in vivo using Plp1 mutant mice.

Main Results:

• Patient-derived oligodendrocytes exhibited ferroptosis, characterized by lipid peroxidation and iron metabolism defects.
• Iron chelation significantly reduced oligodendrocyte apoptosis and improved survival and differentiation.
• Systemic deferiprone treatment in Plp1 mutant mice promoted myelination and reduced cell death.

Conclusions:

• Oligodendrocyte death in PMD is mediated by iron-induced ferroptosis.
• Iron chelation represents a promising therapeutic approach for Pelizaeus-Merzbacher disease.